Francesca Mertan
Papers
1
Total Citations
51
H-Index
1
About
Francesca Mertan is a leading researcher in the field of prostate cancer imaging and biomarker development, with a focus on improving diagnostic accuracy and prognostic assessment through magnetic resonance imaging (MRI). Her most-cited work, "Tumor contact with prostate capsule on magnetic resonance imaging: A potential biomarker for staging and prognosis" (2016, 51 citations), introduced a novel imaging-based metric—the extent of tumor contact with the prostate capsule—as a non-invasive biomarker for predicting extraprostatic extension and patient outcomes. This contribution has advanced the integration of quantitative MRI features into clinical decision-making, offering a more precise alternative to traditional staging methods. Mertan's research bridges radiology and oncology, emphasizing the role of imaging in personalized medicine. Her work is widely recognized for its translational impact, with citations reflecting its influence on subsequent studies in prostate cancer imaging and risk stratification. By identifying simple yet powerful imaging biomarkers, Mertan has helped pave the way for more targeted therapies and improved patient management, making her a notable figure in the evolving landscape of cancer diagnostics.
Research Focus
Key Achievements
Top Papers
- 1